MARÍA MAGDALENA
SALCEDO PLAZA
Profesora asociada de Ciencias de la Salud
Hospital Universitario Puerta de Hierro
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Puerta de Hierro (16)
2023
-
Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration
Hepatology, Vol. 77, Núm. 4, pp. 1095-1105
-
Long term SARS-CoV-2-specific cellular immunity after COVID-19 in liver transplant recipients
Journal of Microbiology, Immunology and Infection, Vol. 56, Núm. 3, pp. 526-536
2022
-
Decreased Long-Term Severe Acute Respiratory Syndrome Coronavirus 2–Specific Humoral Immunity in Liver Transplantation Recipients 12 Months After Coronavirus Disease 2019
Liver Transplantation, Vol. 28, Núm. 6, pp. 1039-1050
-
Early predictors of corticosteroid response in acute severe autoimmune hepatitis: a nationwide multicenter study
Alimentary Pharmacology and Therapeutics, Vol. 56, Núm. 1, pp. 131-143
-
Effects of everolimus plus minimized tacrolimus on kidney function in liver transplantation: REDUCE, a prospective, randomized controlled study
Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, Vol. 114, Núm. 6, pp. 335-342
-
Evaluation and Management of Liver Transplant Candidates with Prior Nonhepatic Cancer: Guidelines from the ILTS/SETH Consensus Conference
Transplantation
2021
-
Tacrolimus as an Effective and Durable Second-Line Treatment for Chronic Autoimmune Hepatitis: A Multicentric Study
Digestive Diseases and Sciences, Vol. 66, Núm. 8, pp. 2826-2832
2020
-
Preliminary Results of a Randomized Clinical Trial of Intravenous Immunoglobulin in Solid Organ Recipients with Severe Infection and Secondary Antibody Deficiency
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, Vol. 39, Núm. 4, pp. S45-S46
2018
-
Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study
American Journal of Transplantation, Vol. 18, Núm. 10, pp. 2513-2522
2017
-
Efficacy and safety of daclatasvir-based antiviral therapy in hepatitis C virus recurrence after liver transplantation. Role of cirrhosis and genotype 3. A multicenter cohort study
Transplant International, Vol. 30, Núm. 10, pp. 1041-1050
-
Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of model for end-stage liver disease: Analysis of data from the Hepa-C registry
Hepatology, Vol. 65, Núm. 6, pp. 1810-1822
2016
-
Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma
Hepatology, Vol. 63, Núm. 2, pp. 488-498
2015
-
Renal function improvement in liver transplant recipients after early everolimus conversion: A clinical practice cohort study in Spain
Liver Transplantation, Vol. 21, Núm. 8, pp. 1056-1065
-
V Reunión de Consenso de la Sociedad Española de Trasplante Hepático sobre receptores de riesgo elevado, escenarios actuales de inmunosupresión y manejo del hepatocarcinoma en espera de trasplante
Cirugia Espanola, Vol. 93, Núm. 10, pp. 619-637
2011
-
Cyclosporine A-based immunosuppression reduces relapse rate after antiviral therapy in transplanted patients with hepatitis C virus infection: A large multicenter cohort study
Transplantation, Vol. 92, Núm. 3, pp. 334-340
2006
-
12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplantation recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus
Liver Transplantation, Vol. 12, Núm. 10, pp. 1464-1472